104 258

Cited 4 times in

The 34th Annual Meeting of the Korean Society of Gynecologic Oncology 2019: meeting report

DC Field Value Language
dc.contributor.author김영태-
dc.date.accessioned2022-08-19T06:26:31Z-
dc.date.available2022-08-19T06:26:31Z-
dc.date.issued2019-07-
dc.identifier.issn2005-0380-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/189173-
dc.description.abstractThe 34th Annual Meeting of Korean Society of Gynecologic Oncology (KSGO) was held in Busan, Korea from 26 to 27 April. Around 460 Korean and international clinicians gathered in Busan to share and discuss their latest work and key issues of gynecologic oncologic research and treatment. The scope of this meeting included recent clinical trials and updates in gynecologic oncology, advances in ovarian cancer treatment, targeted therapy and immunotherapy in gynecologic cancer, management of hereditary gynecologic cancer, and newly revised staging of cervical cancer. As expected, the ongoing debate regarding the recent clinical trial on minimally invasive surgery for early-stage cervical cancer was addressed throughout the congress and the initial outline of the KSGO position statement was open for discussion. The meeting was an opportunity for all participants to come together and explore scientific insights of gynecologic cancer.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherAsian Society of Gynecologic Oncology : Taehan Puin Chongyang Hakhoe-
dc.relation.isPartOfJOURNAL OF GYNECOLOGIC ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleThe 34th Annual Meeting of the Korean Society of Gynecologic Oncology 2019: meeting report-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Obstetrics and Gynecology (산부인과학교실)-
dc.contributor.googleauthorGa Won Yim-
dc.contributor.googleauthorDong Hoon Suh-
dc.contributor.googleauthorJae Weon Kim-
dc.contributor.googleauthorSeung Cheol Kim-
dc.contributor.googleauthorYoung Tae Kim-
dc.identifier.doi10.3802/jgo.2019.30.e91-
dc.contributor.localIdA00729-
dc.relation.journalcodeJ01428-
dc.identifier.eissn2005-0399-
dc.identifier.pmid31140217-
dc.subject.keywordUterine Cervical Neoplasms-
dc.subject.keywordOvarian Neoplasms-
dc.subject.keywordEndometrial Neoplasms-
dc.subject.keywordMolecular Targeted Therapy-
dc.subject.keywordImmunotherapy-
dc.contributor.alternativeNameKim, Young Tae-
dc.contributor.affiliatedAuthor김영태-
dc.citation.volume30-
dc.citation.number4-
dc.citation.startPagee91-
dc.identifier.bibliographicCitationJOURNAL OF GYNECOLOGIC ONCOLOGY, Vol.30(4) : e91, 2019-07-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Obstetrics and Gynecology (산부인과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.